{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:36:41Z","timestamp":1772901401611,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013103","name":"Shanghai General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271111"],"award-info":[{"award-number":["82271111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.exer.2025.110633","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:40:50Z","timestamp":1757374850000},"page":"110633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ADAMTS13-mediated angiogenesis by PLK-1\/Ang-2 is independent of VEGF in diabetic retinopathy"],"prefix":"10.1016","volume":"260","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6470-7791","authenticated-orcid":false,"given":"Yujin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yikeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-0240","authenticated-orcid":false,"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1755-3768.2009.01700.x","article-title":"Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes","volume":"89","author":"Abu El-Asrar","year":"2011","journal-title":"Acta Ophthalmol."},{"issue":"18","key":"10.1016\/j.exer.2025.110633_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27185977","article-title":"Differential expression and localization of ADAMTS proteinases in proliferative diabetic retinopathy","volume":"27","author":"Abu El-Asrar","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells14020085","article-title":"ADAMTS13 improves endothelial function and reduces inflammation in diabetic retinopathy","volume":"14","author":"Abu El-Asrar","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.exer.2025.110633_bib5","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","article-title":"Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies","volume":"122","author":"Brown","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib6","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","year":"2021","journal-title":"Lancet Global Health"},{"issue":"10","key":"10.1016\/j.exer.2025.110633_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102778","article-title":"Beyond VEGF: angiopoietin-Tie signaling pathway in diabetic retinopathy","volume":"13","author":"Chen-Li","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2025.110633_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"16 Suppl. l","key":"10.1016\/j.exer.2025.110633_bib9","article-title":"Addressing unmet needs in diabetic retinopathy","volume":"25","author":"Coney","year":"2019","journal-title":"Am. J. Manag. Care"},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-016-4139-5","article-title":"ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study","volume":"60","author":"de Vries","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2025.110633_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2016.05.011","article-title":"Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-Dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus","volume":"459","author":"Domingueti","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.exer.2025.110633_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2315260","article-title":"Association of haemostatic and inflammatory biomarkers with nephropathy in type 1 diabetes mellitus","volume":"2016","author":"Domingueti","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.exer.2025.110633_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.exer.2025.110633_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12185-016-2091-2","article-title":"ADAMTS13: more than a regulator of thrombosis","volume":"104","author":"Feng","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.exer.2025.110633_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02981975","article-title":"Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.exer.2025.110633_bib16","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41433-024-03101-5","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020","volume":"38","year":"2024","journal-title":"Eye (Lond)."},{"issue":"7","key":"10.1016\/j.exer.2025.110633_bib17","first-page":"602","article-title":"[Inhibitory effect of von Willebrand factor-cleaving protease on angiogenesis]","volume":"36","author":"Jin","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"21","key":"10.1016\/j.exer.2025.110633_bib18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.exer.2025.110633_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond)."},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mvr.2012.05.004","article-title":"ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis","volume":"84","author":"Lee","year":"2012","journal-title":"Microvasc. Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00018-014-1667-3","article-title":"ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2","volume":"72","author":"Lee","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib22","article-title":"Ophthalmic solution of smart supramolecular peptides to capture semaphorin 4D against diabetic retinopathy","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.exer.2025.110633_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12933-016-0342-4","article-title":"High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy","volume":"15","author":"Madonna","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.exer.2025.110633_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2024.1319840","article-title":"Associated factors of diabetic retinopathy in type 1 and 2 diabetes in Limpopo province in South Africa","volume":"5","author":"Maluleke","year":"2024","journal-title":"Front Clin Diabetes Healthc"},{"issue":"5","key":"10.1016\/j.exer.2025.110633_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2007.06694.x","article-title":"Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura","volume":"138","author":"Manea","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.exer.2025.110633_bib26","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.exer.2025.110633_bib27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199404143301503","article-title":"Genetic susceptibility to death from coronary heart disease in a study of twins","volume":"330","author":"Marenberg","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2025.110633_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","article-title":"ADAMTS proteins in human disorders","volume":"71\u201372","author":"Mead","year":"2018","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.exer.2025.110633_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.exer.2025.110633_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11892-013-0382-z","article-title":"Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema","volume":"13","author":"Owen","year":"2013","journal-title":"Curr. Diabetes Rep."},{"issue":"9","key":"10.1016\/j.exer.2025.110633_bib31","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2337\/db13-1942","article-title":"Angiopoietin 2 induces pericyte apoptosis via \u03b13\u03b21 integrin signaling in diabetic retinopathy","volume":"63","author":"Park","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.exer.2025.110633_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2013.05.024","article-title":"Simvastatin increases ADAMTS13 expression in podocytes","volume":"132","author":"Shen","year":"2013","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.exer.2025.110633_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mvr.2010.01.005","article-title":"High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1","volume":"79","author":"Singh","year":"2010","journal-title":"Microvasc. Res."},{"issue":"11","key":"10.1016\/j.exer.2025.110633_bib34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/jth.13479","article-title":"Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam study","volume":"14","author":"Sonneveld","year":"2016","journal-title":"J. Thromb. Haemostasis : JTH"},{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.exer.2025.110633_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.03.002","article-title":"ADAMTS-13 is produced by glial cells and upregulated after spinal cord injury","volume":"517","author":"Tauchi","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","article-title":"Localization of ADAMTS13 to the stellate cells of human liver","volume":"106","author":"Uemura","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.exer.2025.110633_bib38","first-page":"464","article-title":"The expression of ADAMTS13 in human microvascular endothelial cells. Blood coagulation & fibrinolysis","volume":"27","author":"Wang","year":"2016","journal-title":"Int. J. Hostasis Tombosis"},{"issue":"6","key":"10.1016\/j.exer.2025.110633_bib39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.exer.2025.110633_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.exer.2025.110633_bib41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005-2008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.exer.2025.110633_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/cjop.CJOP-D-23-00101","article-title":"ADAMTS13 inhibits H(2)O(2)-induced human venous endothelial cell injury to attenuate deep-vein thrombosis by blocking the p38\/ERK signaling pathway","volume":"66","author":"Zheng","year":"2023","journal-title":"Chin. J. Physiol."},{"issue":"19","key":"10.1016\/j.exer.2025.110633_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160517","article-title":"FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1","volume":"133","author":"Zhou","year":"2023","journal-title":"J. Clin. Investig."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352500404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352500404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:17:10Z","timestamp":1772835430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352500404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S001448352500404X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110633","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAMTS13-mediated angiogenesis by PLK-1\/Ang-2 is independent of VEGF in diabetic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110633"}}